tirzepatide surmount 3 A 3-year study of in participants with obesity and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo. Full SURMOUNT-1 Diabetes Dialogue: SURMOUNT-3 and -4
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 21 - Nov 26







:max_bytes(150000):strip_icc()/IMG_1967-faea25b4cb674cee8507e1f5ff625f0e.jpg)

















